These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34611682)

  • 1. The CRISPR-Cas toolbox for analytical and diagnostic assay development.
    Tang Y; Gao L; Feng W; Guo C; Yang Q; Li F; Le XC
    Chem Soc Rev; 2021 Nov; 50(21):11844-11869. PubMed ID: 34611682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress and bioapplication of CRISPR-based one-step, quantitative and multiplexed infectious disease diagnostics.
    Shen Y; Hu K; Yuan M; Duan G; Guo Y; Chen S
    J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36813257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of the CRISPR-Cas system for infectious disease diagnostics.
    Li P; Wang L; Yang J; Di LJ; Li J
    Expert Rev Mol Diagn; 2021 Jul; 21(7):723-732. PubMed ID: 33899643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities.
    van Dongen JE; Berendsen JTW; Steenbergen RDM; Wolthuis RMF; Eijkel JCT; Segerink LI
    Biosens Bioelectron; 2020 Oct; 166():112445. PubMed ID: 32758911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in biosensing: The CRISPR/Cas system as a new powerful tool for the detection of nucleic acids.
    Bonini A; Poma N; Vivaldi F; Kirchhain A; Salvo P; Bottai D; Tavanti A; Di Francesco F
    J Pharm Biomed Anal; 2021 Jan; 192():113645. PubMed ID: 33039910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas-Based Techniques for Live-Cell Imaging and Bioanalysis.
    Huang S; Dai R; Zhang Z; Zhang H; Zhang M; Li Z; Zhao K; Xiong W; Cheng S; Wang B; Wan Y
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating CRISPR/Cas within isothermal amplification for point-of-Care Assay of nucleic acid.
    Zhang L; Jiang H; Zhu Z; Liu J; Li B
    Talanta; 2022 Jun; 243():123388. PubMed ID: 35303554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and Opportunities for Clustered Regularly Interspaced Short Palindromic Repeats Based Molecular Biosensing.
    Bao M; Chen Q; Xu Z; Jensen EC; Liu C; Waitkus JT; Yuan X; He Q; Qin P; Du K
    ACS Sens; 2021 Jul; 6(7):2497-2522. PubMed ID: 34143608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-based biosensing systems: a way to rapidly diagnose COVID-19.
    Vatankhah M; Azizi A; Sanajouyan Langeroudi A; Ataei Azimi S; Khorsand I; Kerachian MA; Motaei J
    Crit Rev Clin Lab Sci; 2021 Jun; 58(4):225-241. PubMed ID: 33245685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas based virus detection: Recent advances and perspectives.
    Yin L; Man S; Ye S; Liu G; Ma L
    Biosens Bioelectron; 2021 Dec; 193():113541. PubMed ID: 34418634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal amplification and output of CRISPR/Cas-based biosensing systems: A review.
    Wang SY; Du YC; Wang DX; Ma JY; Tang AN; Kong DM
    Anal Chim Acta; 2021 Nov; 1185():338882. PubMed ID: 34711321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas-Based In Vitro Diagnostic Platforms for Cancer Biomarker Detection.
    Gong S; Zhang S; Lu F; Pan W; Li N; Tang B
    Anal Chem; 2021 Sep; 93(35):11899-11909. PubMed ID: 34427091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of CRISPR/Cas-based biosensors for detecting nucleic acid of pathogens].
    Liu T; Tian Y; Liu C; Fang S; Wu Y; Wu M; Li B; Yang H; Liu Q
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3890-3904. PubMed ID: 34841793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.
    Weng Z; You Z; Yang J; Mohammad N; Lin M; Wei Q; Gao X; Zhang Y
    Angew Chem Int Ed Engl; 2023 Apr; 62(17):e202214987. PubMed ID: 36710268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed Detection Strategies for Biosensors Based on the CRISPR-Cas System.
    Wei C; Lei X; Yu S
    ACS Synth Biol; 2024 Jun; 13(6):1633-1646. PubMed ID: 38860462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel nucleic acid detection strategies based on CRISPR-Cas systems: From construction to application.
    Zhu CS; Liu CY; Qiu XY; Xie SS; Li WY; Zhu L; Zhu LY
    Biotechnol Bioeng; 2020 Jul; 117(7):2279-2294. PubMed ID: 32175589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR Enzyme Kinetics for Molecular Diagnostics.
    Ramachandran A; Santiago JG
    Anal Chem; 2021 May; 93(20):7456-7464. PubMed ID: 33979119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancements of CRISPR technology in public health-related analysis.
    Gu X; Tang Q; Zhu Y; Sun C; Wu L; Ji H; Wang Q; Wu L; Qin Y
    Biosens Bioelectron; 2024 Oct; 261():116449. PubMed ID: 38850734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress and challenges towards CRISPR/Cas clinical translation.
    Rosenblum D; Gutkin A; Dammes N; Peer D
    Adv Drug Deliv Rev; 2020; 154-155():176-186. PubMed ID: 32659256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas enzymes: The toolkit revolutionizing diagnostics.
    Verosloff MS; Shapiro SJ; Hawkins EM; Alpay E; Verma D; Stanfield EG; Kreindler L; Jain S; McKay B; Hubbell SA; Hendriks CG; Blizard BA; Broughton JP; Chen JS
    Biotechnol J; 2022 Jul; 17(7):e2100304. PubMed ID: 34505742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.